Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies

Download All
Faculty assess the metabolic adaptations in obesity, the value of sustained weight loss and related complications, and the latest evidence for incretin-based therapies for long-term weight management.
Laurie E. Cohen, MD
Randy J. Seeley, PhD
Jenny Tong, MD, MPH
Kristina M. Utzschneider, MD
Steven G. Waguespack, MD

Downloadable Slideset

Learn about the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management.

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Released: March 17, 2021

ClinicalThought

Here’s how I dose incretins and how I address potential GI adverse events, pancreatitis, and gallstones.

Kristina M. Utzschneider, MD Released: April 12, 2021

On Demand Webcast

From ENDO 2021, expert faculty assess the metabolic adaptations in obesity, the value of sustained weight loss, and the latest evidence for incretin-based therapies for long-term weight management

Laurie E. Cohen, MD Randy J. Seeley, PhD Steven G. Waguespack, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: March 20, 2021 Expired: March 31, 2022
Provided by Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue